Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous Moxifloxacin in Pediatric Patients: Dose Optimization in a Phase 1 Study

Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance

(2018) Eva Germovsek et al.   CLINICAL PHARMACOKINETICS

Moxifloxacin in Pediatric Patients With Complicated Intra-abdominal Infections

(2018) Stefan Wirth et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The Use of Systemic and Topical Fluoroquinolones

(2016) Mary Anne Jackson et al.   PEDIATRICS

Pharmacokinetics and Safety of Moxifloxacin in Children With Multidrug-Resistant Tuberculosis

(2014) Stephanie Thee et al.   CLINICAL INFECTIOUS DISEASES

Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America

(2014) Dennis L. Stevens et al.   CLINICAL INFECTIOUS DISEASES

Assessment of Musculoskeletal Toxicity 5 Years After Therapy With Levofloxacin

(2014) J. S. Bradley et al.   PEDIATRICS

Development of a Paediatric Population-Based Model of the Pharmacokinetics of Rivaroxaban

(2013) Stefan Willmann et al.   CLINICAL PHARMACOKINETICS

2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections

(2012) B. A. Lipsky et al.   CLINICAL INFECTIOUS DISEASES

First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug development

(2012) Ashley Strougo et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Susceptibility ofStreptococcus pneumoniaeto Fluoroquinolones in Canada

(2011) Samir N. Patel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America

(2011) John S. Bradley et al.   CLINICAL INFECTIOUS DISEASES

Diagnosis and Management of Complicated Intra‐abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America

(2009) Joseph S. Solomkin et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetics and Tissue Penetration of Moxifloxacin in??Intervention Therapy for Intra-Abdominal Abscess

(2008) Andreas D Rink et al.   CLINICAL DRUG INVESTIGATION

The Effect of Moxifloxacin on QTc and Implications for the Design of Thorough QT Studies

(2008) DM Bloomfield et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Single- and multiple-dose pharmacokinetics of intravenous moxifloxacin in patients with severe hepatic impairment

(2008) J. Barth et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY